Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Contraceptive, Progesterone, and Inositol in PCOS
NCT07242131Recruiting
- Sponsor
- Ege University
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of bCalm and dydrogesterone in polycystic ovary syndrome (PCOS) (3 arms), sponsored by Ege University. Primary endpoint: Restoration of Regular Menstrual Cycles at 6 months. Started Dec 2025; status: recruiting.
02
Drugs
bCalmdydrogesterone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07242131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07242131.